No Data
Immunic Stock (IMUX): Understanding the Current Status and Future Path for IMU-838
Express News | Immunic-Files Prospectus Supplement for Sale $80.0 Mln of Shares of Common Stock, May Offer & Sell From Time to Time Through Leerink Partners
Express News | Immunic Inc -Had Previously Entered Into Sales Agreement With Leerink Partners Dated May 2, 2022 Relating to Shares of Common Stock
When Will Immunic, Inc. (NASDAQ:IMUX) Breakeven?
Immunic Inc. CEO Daniel Vitt Highlights Advances in MS Treatment on World MS Day | NASDAQ:IMUX
Immunic to Participate in Industry and Scientific Conferences in June
Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic...